VRNA - Verona Pharma Plc - ADR
IEX Last Trade
27.49
1.480 5.384%
Share volume: 1,225,274
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$26.01
1.48
5.69%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-03 | 2022-08-09 | 2022-11-09 | 2023-03-07 | 2023-05-09 | 2023-08-03 | 2023-11-02 | |
| Assets | ||||||||
| Total Assets | 169.315 M | 154.856 M | 274.872 M | 259.468 M | 323.146 M | 303.929 M | 292.470 M | |
| Current Assets | 152.955 M | 138.632 M | 258.454 M | 242.996 M | 306.891 M | 287.831 M | 276.527 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.771 M | 6.937 M | 6.432 M | 5.887 M | 3.634 M | 6.954 M | 9.651 M | |
| Short Term Investments | 3.771 M | 6.937 M | 6.432 M | 5.887 M | 3.634 M | 6.954 M | 9.651 M | |
| Total Receivables | 16.420 M | 20.185 M | 20.321 M | 9.282 M | 11.842 M | 10.150 M | 9.510 M | |
| Current Cash | 132.764 M | 111.510 M | 231.701 M | 227.827 M | 291.415 M | 270.727 M | 257.366 M | |
| Total Non-current Assets | 16.360 M | 16.224 M | 16.418 M | 16.472 M | 16.255 M | 16.098 M | 15.943 M | |
| Property Plant Equipment | 71.000 K | 91.000 K | 81.000 K | 73.000 K | 12.000 K | 11.000 K | 10.000 K | |
| Other Assets | 744.000 K | 588.000 K | 793.000 K | 854.000 K | 698.000 K | 542.000 K | 388.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 545.000 K | 545.000 K | 544.000 K | 545.000 K | 545.000 K | 545.000 K | 545.000 K | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 169.315 M | 154.856 M | 274.872 M | 259.468 M | 323.146 M | 303.929 M | 292.470 M | |
| Total liabilities | 43.008 M | 43.976 M | 37.387 M | 29.002 M | 46.397 M | 30.836 M | 28.937 M | |
| Total current liabilities | 37.903 M | 38.863 M | 32.128 M | 19.029 M | 26.523 M | 10.949 M | 9.012 M | |
| Accounts Payable | 8.064 M | 9.364 M | 8.002 M | 2.910 M | 7.237 M | 2.493 M | 823.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 583.000 K | 464.000 K | 569.000 K | 675.000 K | 650.000 K | 545.000 K | 376.000 K | |
| Long term debt | 5.105 M | 5.113 M | 5.259 M | 9.973 M | 19.874 M | 19.887 M | 19.925 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 126.307 M | 110.880 M | 237.485 M | 230.466 M | 276.749 M | 273.093 M | 263.533 M | |
| Common stock | 481.942 M | 484.778 M | 544.134 M | 605.433 M | 621.451 M | 634.469 M | 638.239 M | |
| Retained earnings | -288.739 M | -306.653 M | -322.442 M | -333.097 M | -350.110 M | -359.143 M | -374.053 M |